Drugs / Floxuridin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06888063 | Nov 2024 → Sep 2026 overdue | intrahepatic cholangiocarcinoma | Erasmus Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Floxuridin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06888063 ↗ |
| Route | Other | “Hepatic Arterial Infusion Pump chemotherapy” NCT06888063 ↗ |